Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
01 Nov 2024
Historique:
received: 08 03 2024
accepted: 22 04 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Benign prostatic obstruction (BPO) is one of the most common causes of male lower urinary tract symptoms. Some institutions routinely perform BPO surgeries in ambulatory setting, while others elect for overnight hospitalization. With the COVID-19 pandemic limiting resources and hospital space for elective surgery, we investigated the time trend of ambulatory BPO procedures performed around the COVID-19 outbreak. We identified BPO surgeries from the California State Inpatient and State Ambulatory Surgery Databases between 2018 and 2020. Our primary outcome was the proportion of procedures performed in ambulatory settings with a length of stay of zero days. Univariable and multivariable analyses were performed to analyze factors associated with ambulatory surgery around the COVID-19 outbreak. Spline regression with a knot at the pandemic outbreak was performed to compare time trends pre- and post-pandemic. Among 37,148 patients who underwent BPO procedures, 30,067 (80.9%) were ambulatory. Before COVID-19, 80.1% BPO procedures were performed ambulatory, which increased to 83.4% after COVID-19 outbreak (p < 0.001). In multivariable model, BPO procedures performed after COVID-19 outbreak were 1.26 times more likely to be ambulatory (OR 1.26, 95% CI 1.14-1.40, p < 0.0001). Spline curve analysis indicated significantly different trend of change pre- and post-pandemic (p = 0.006). We observed a rising trend of BPO surgeries performed in ambulatory setting post-pandemic. It remains to be seen if the observed ambulatory transition remains as we continue to recover from the pandemic.

Identifiants

pubmed: 39485508
doi: 10.1007/s00345-024-05343-0
pii: 10.1007/s00345-024-05343-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

613

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Chughtai B, Forde JC, Thomas DDM et al (2016) Benign prostatic hyperplasia. Nat Rev Dis Primers 2(1):1–15
doi: 10.1038/nrdp.2016.31
Welch G, Weinger K, Barry MJ (2002) Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 59(2):245–250
doi: 10.1016/S0090-4295(01)01506-0 pubmed: 11834396
Lerner LB, McVary KT, Barry MJ et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I—initial work-up and medical management. J Urol 206(4):806–817
doi: 10.1097/JU.0000000000002183 pubmed: 34384237
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50(5):969–980
doi: 10.1016/j.eururo.2005.12.042 pubmed: 16469429
Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109
doi: 10.1016/j.eururo.2014.12.038 pubmed: 25613154
Ljungqvist O, Scott M, Fearon KC (2017) Enhanced recovery after surgery: a review. JAMA Surg 152(3):292–298
doi: 10.1001/jamasurg.2016.4952 pubmed: 28097305
Pędziwiatr M, Mavrikis J, Witowski J et al (2018) Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery. Med Oncol 35:1–8
doi: 10.1007/s12032-018-1153-0
Nguyen D-D, Marchese M, Ozambela M et al (2020) Ambulatory-based bladder outlet procedures offer significant cost savings and comparable 30-day outcomes relative to inpatient procedures. J Endourol 34(12):1248–1254
doi: 10.1089/end.2019.0684 pubmed: 32178528 pmcid: 7757614
Friedlander DF, Krimphove MJ, Cole AP et al (2021) Where is the value in ambulatory versus inpatient surgery? Ann Surg 273(5):909–916
doi: 10.1097/SLA.0000000000003578 pubmed: 31460878
Berger A, Friedlander DF, Herzog P et al (2019) Impact of index surgical care setting on perioperative outcomes and cost following penile prosthesis surgery. J Sex Med 16(9):1451–1458
doi: 10.1016/j.jsxm.2019.07.004 pubmed: 31405770
Majholm B, Engbæk J, Bartholdy J et al (2012) Is day surgery safe? AD anish multicentre study of morbidity after 57,709 day surgery procedures. Acta Anaesthesiol Scand 56(3):323–331
doi: 10.1111/j.1399-6576.2011.02631.x pubmed: 22335277
Das AK, Leong JY, Roehrborn CG (2019) Office-based therapies for benign prostatic hyperplasia: a review and update. Can J Urol 26(4 Suppl 1):2–7
pubmed: 31481142
Salciccia S, Del Giudice F, Maggi M et al (2021) Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis. J Endourol 35(4):395–408
doi: 10.1089/end.2020.0538 pubmed: 33081521
Malaeb BS, Yu X, McBean AM, Elliott SP (2012) National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008). Urology 79(5):1111–1117
doi: 10.1016/j.urology.2011.11.084 pubmed: 22546389
Diaz A, Sarac BA, Schoenbrunner AR, Janis JE, Pawlik TM (2020) Elective surgery in the time of COVID-19. Am J Surg 219(6):900–902
doi: 10.1016/j.amjsurg.2020.04.014 pubmed: 32312477 pmcid: 7161516
Jain A, Dai T BK, Myers C (2020) Covid-19 created an elective surgery backlog: how can hospitals get back on track. Harvard Bus Rev. 10(1)
Liang ZC, Chong MSY, Liu GKP et al (2021) COVID-19 and elective surgery: 7 practical tips for a safe, successful, and sustainable reboot. Ann Surg 273(2):e39–e40
doi: 10.1097/SLA.0000000000004091 pubmed: 32433295
Ditonno F, Autorino R (2023) Editorial comment. Urol Pract 10(6):637–638. https://doi.org/10.1097/UPJ.0000000000000452.01
doi: 10.1097/UPJ.0000000000000452.01 pubmed: 37856721
Teoh JY-C, Ong WLK, Gonzalez-Padilla D et al (2020) A global survey on the impact of COVID-19 on urological services. Eur Urol 78(2):265–275
doi: 10.1016/j.eururo.2020.05.025 pubmed: 32507625 pmcid: 7248000
Cole AP, Friedlander DF, Trinh Q-D (2018) Secondary data sources for health services research in urologic oncology. Elsevier, pp. 165–173
Wahba G (1990) Spline models for observational data. SIAM
Lwin AA, Zeng J, Evans P et al (2020) Holmium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology 138:119–124
doi: 10.1016/j.urology.2020.01.014 pubmed: 31962119
Agarwal DK, Large T, Tong Y et al (2022) Same day discharge is a successful approach for the majority of patients undergoing holmium laser enucleation of the prostate. Eur Urol Focus 8(1):228–234
doi: 10.1016/j.euf.2020.12.018 pubmed: 33414073

Auteurs

Zhiyu Qian (Z)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Dejan Filipas (D)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Edoardo Beatrici (E)

Department of Urology, Humanitas Clinical and Research Hospital, Milan, Italy.

Jamie Ye (J)

Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Mansoo Cho (M)

Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Filippo Dagnino (F)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Hanna Zurl (H)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Daniel Stelzl (D)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

David F Friedlander (DF)

Department of Urology, University of North Carolina Medical Center, Chapel Hill, NC, USA.

Quoc-Dien Trinh (QD)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Stuart R Lipsitz (SR)

Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Alexander P Cole (AP)

Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Lori B Lerner (LB)

Department of Surgery, VA Boston Healthcare System, West Roxbury, MA, USA. lerner_lori@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH